Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.

about

The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy.

P2860

Q48098253-9EAC0E14-87C0-40EC-81C2-04C1B0022D84 Q49189946-A6027835-BD10-4AAF-8558-70FD25DDFD09

P2860

Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.

Item

http://www.wikidata.org/entity/Q38821926

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical risk scores in the cu ...... r colorectal liver metastases.

@en

type

Item

label

Clinical risk scores in the cu ...... r colorectal liver metastases.

@en

prefLabel

Clinical risk scores in the cu ...... r colorectal liver metastases.

@en

P1476

Clinical risk scores in the cu ...... r colorectal liver metastases.

@en

P2093

Ashley R Dennison

http://www.w3.org/2001/XMLSchema#string

Christopher P Neal

http://www.w3.org/2001/XMLSchema#string

Giuseppe Garcea

http://www.w3.org/2001/XMLSchema#string

Rohan Kumar

http://www.w3.org/2001/XMLSchema#string

Vaux Robertson

http://www.w3.org/2001/XMLSchema#string

P2860

'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.

Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?

Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?

Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases.

Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases.

Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy.

Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?

Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.

P304

E16-E20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANS.13688

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael J Jones

P577

2016-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27621179

http://www.w3.org/2001/XMLSchema#string

Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.

about

P2860

P2860

Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698